API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206029
https://www.prnewswire.com/news-releases/upsher-smith-launches-pitavastatin-tablets-301977553.html
https://www.prnewswire.com/news-releases/medicure-announces-a-direct-to-patient-online-pharmacy-program-for-distribution-of-zypitamag-pitavastatin-tablets-301083656.html
https://www.prnewswire.com/news-releases/medicure-announces-a-direct-to-patient-online-pharmacy-program-for-distribution-of-zypitamag-pitavastatin-tablets-301083656.html
https://www.prnewswire.com/news-releases/medicure-announces-preferred-pricing-agreement-for-zypitamag-with-the-aids-drug-assistance-program-adap-crisis-task-force-300931003.html
https://www.prnewswire.com/news-releases/medicure-announces-acquisition-of-full-united-states-ownership-of-zypitamag-300927426.html
https://www.prnewswire.com/news-releases/medicure-announces-availability-of-zypitamag-pitavastatin-in-the-us-300639473.html
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-receives-usfda-nod-for-cholesterol-drug/articleshow/59983033.cms
https://www.pharmacompass.com/pdf/news/livalo-pitavastatin-calcium-kowa-company-ltd-et-al-vhetero-drugs-limited-1497850887.pdf
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205932
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205955
https://globenewswire.com/news-release/2017/01/03/902962/0/en/CymaBay-Announces-Exclusive-Licensing-Agreement-with-Kowa-Pharmaceuticals-America-Inc-for-the-Development-and-Commercialization-of-Arhalofenate-in-the-United-States.html
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206029
http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206015
https://www.pharmacompass.com/pdf/news/zhejiang-hisun-pharmaceutical-co-ltd-yantou-campus-fails-edqm-inspection-1483966941.pdf
http://www.prnewswire.com/news-releases/new-data-demonstrate-pitavastatin-more-effective-than-pravastatin-in-improving-inflammatory-and-immune-activation-markers-in-hiv-infected-patients-300287527.html